Moderna Inc. recorded a quarterly loss as vaccine sales waned and the company had an unexpected charge for a canceled ...

Moderna CEO Stéphane Bancel deflected concerns about the new presidential administration's potential impact on life sciences ...

As Bakey opens it fourth and newest location, the renowned Boston bakery plans to stay devoted to churning out fresh pastries ...

Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 billion of non-cash charges related to manufacturing resizing ...

The vote deregulates land use, loosening rules that limited what Cambridge landowners could do with their property.

It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...

It's the second time in less than three months that the Waltham-based life sciences firm has announced layoffs.

Moderna (NASDAQ:MRNA) traded lower in the premarket on Wednesday after Goldman Sachs downgraded the COVID-19 vaccine maker to Neutral from Buy, citing a lack of clarity over its revenue outlook.

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for priority review a supplemental new drug application ...

Merck is investigating WELIREG in rare oncologic diseases, RCC and other tumor types through a broad clinical development program, including in Phase 2 and 3 trials evaluating WELIREG as monotherapy ...

As a young physiology student Tipu Aziz was inspired by watching grainy videos from the 1970s showing patients undergoing brain surgery for movement disorders such as Parkinson’s disease. The films ...

DAVOS, Switzerland, Jan 23 (Reuters) - The CEO of Germany's Merck KGaA (MRCG.DE), opens new tab on Thursday said a recovery in sales growth at its existing business means it can take a cautious ...